BioGenCell

1 stories about BioGenCell
BioGenCell

BioGenCell pioneers revolutionary cell therapy for microvascular disease

11.07.24|Ariela Karmel
CEO Yael Porat spoke to CTech about the Israeli biotech company’s groundbreaking cell therapy technology for the common and debilitating disease whose primary treatment today is amputation 
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1